Literature DB >> 19056749

A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.

Dirk R J Kuypers, Bert Bammens, Kathleen Claes, Pieter Evenepoel, Evelyne Lerut, Yves Vanrenterghem.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056749     DOI: 10.1093/jac/dkn495

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.

Authors:  Thurid Ahlenstiel-Grunow; Lars Pape
Journal:  Pediatr Nephrol       Date:  2018-12-11       Impact factor: 3.714

Review 2.  Management of polyomavirus-associated nephropathy in renal transplant recipients.

Authors:  Dirk R J Kuypers
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

3.  1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells.

Authors:  Christine Hanssen Rinaldo; Rainer Gosert; Eva Bernhoff; Solrun Finstad; Hans H Hirsch
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

Review 4.  Advances in BK Virus Complications in Organ Transplantation and Beyond.

Authors:  Abraham Cohen-Bucay; Silvia E Ramirez-Andrade; Craig E Gordon; Jean M Francis; Vipul C Chitalia
Journal:  Kidney Med       Date:  2020-10-11

5.  Intracellular Low Iron Exerts Anti-BK Polyomavirus Effect by Inhibiting the Protein Synthesis of Exogenous Genes.

Authors:  Jiajia Sun; Yejing Shi; Huichun Shi; Yumin Hou; Chunlan Hu; Yigang Zeng; Guoyi Wu; Tongyu Zhu
Journal:  Microbiol Spectr       Date:  2021-11-10

Review 6.  Human polyomavirus reactivation: disease pathogenesis and treatment approaches.

Authors:  Cillian F De Gascun; Michael J Carr
Journal:  Clin Dev Immunol       Date:  2013-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.